My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 101

    1.

    Co-existence of acute myeloid leukemia with multilineage dysplasia and Epstein-Barr virus-associated T-cell lymphoproliferative disorder in a patient with rheumatoid arthritis: a case report.

    Tokuhira M, Hanzawa K, Watanabe R, Sekiguchi Y, Nemoto T, Toyozumi Y, Tamaru J, Itoyama S, Suzuki K, Kameda H, Mori S, Kizaki M.

    J Hematol Oncol. 2009 Jun 30;2:27.PMID: 19566938 [PubMed - in process]Related articlesFree article

    2.

    Lymphoproliferative disorders in autoimmune diseases in Japan: analysis of clinicopathological features and Epstein-Barr virus infection.

    Hoshida Y, Tomita Y, Zhiming D, Yamauchi A, Nakatsuka S, Kurasono Y, Arima Y, Tsudo M, Shintaku M, Aozasa K.

    Int J Cancer. 2004 Jan 20;108(3):443-9.PMID: 14648712 [PubMed - indexed for MEDLINE]Related articles

    4.

    B-Cell lymphoproliferative disorder not associated with Epstein-Barr Virus in a child with relapsed acute lymphoblastic leukemia.

    Lehrnbecher T, Trusen A, Deinlein F, Höcht B, Marx A, Kühl J.

    Med Pediatr Oncol. 2003 Jan;40(1):13-7. Review.PMID: 12426680 [PubMed - indexed for MEDLINE]Related articles

    5.
    6.

    Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults.

    Suzuki K, Ohshima K, Karube K, Suzumiya J, Ohga S, Ishihara S, Tamura K, Kikuchi M.

    Int J Oncol. 2004 May;24(5):1165-74.PMID: 15067338 [PubMed - indexed for MEDLINE]Related articles

    7.

    Reversible infliximab-related lymphoproliferative disorder associated with Epstein-Barr virus in a patient with rheumatoid arthritis.

    Komatsuda A, Wakui H, Nimura T, Sawada K.

    Mod Rheumatol. 2008;18(3):315-8. Epub 2008 Mar 28.PMID: 18368468 [PubMed - indexed for MEDLINE]Related articles

    9.

    A population based, case control study of non-Hodgkin's lymphoma in patients with rheumatoid arthritis.

    Kamel OW, Holly EA, van de Rijn M, Lele C, Sah A.

    J Rheumatol. 1999 Aug;26(8):1676-80.PMID: 10451061 [PubMed - indexed for MEDLINE]Related articles

    10.

    Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes.

    Tan LC, Mowat AG, Fazou C, Rostron T, Roskell H, Dunbar PR, Tournay C, Romagné F, Peyrat MA, Houssaint E, Bonneville M, Rickinson AB, McMichael AJ, Callan MF.

    Arthritis Res. 2000;2(2):154-64. Epub 2000 Feb 7.PMID: 11062606 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan.

    Sato E, Ohga S, Kuroda H, Yoshiba F, Nishimura M, Nagasawa M, Inoue M, Kawa K.

    Am J Hematol. 2008 Sep;83(9):721-7.PMID: 18626884 [PubMed - indexed for MEDLINE]Related articles

    12.

    Unrelated bone marrow transplantation for Epstein-Barr virus-associated T/NK-cell lymphoproliferative disease.

    Okamura T, Kishimoto T, Inoue M, Honda M, Yamashita N, Wakiguchi H, Yagita M, Hosoi G, Sako M, Yasui M, Yagi K, Kawa K.

    Bone Marrow Transplant. 2003 Jan;31(2):105-11.PMID: 12621491 [PubMed - indexed for MEDLINE]Related articles

    13.

    Molecular quantification of viral load in plasma allows for fast and accurate prediction of response to therapy of Epstein-Barr virus-associated lymphoproliferative disease after allogeneic stem cell transplantation.

    van Esser JW, Niesters HG, Thijsen SF, Meijer E, Osterhaus AD, Wolthers KC, Boucher CA, Gratama JW, Budel LM, van der Holt B, van Loon AM, Löwenberg B, Verdonck LF, Cornelissen JJ.

    Br J Haematol. 2001 Jun;113(3):814-21.PMID: 11380475 [PubMed - indexed for MEDLINE]Related articles

    14.

    Epstein-Barr virus-associated lymphoproliferative disease during methotrexate therapy for psoriasis.

    Paul C, Le Tourneau A, Cayuela JM, Devidas A, Robert C, Molinié V, Dubertret L.

    Arch Dermatol. 1997 Jul;133(7):867-71.PMID: 9236525 [PubMed - indexed for MEDLINE]Related articles

    15.

    Proposed categorization of pathological states of EBV-associated T/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: overlap with chronic active EBV infection and infantile fulminant EBV T-LPD.

    Ohshima K, Kimura H, Yoshino T, Kim CW, Ko YH, Lee SS, Peh SC, Chan JK; CAEBV Study Group.

    Pathol Int. 2008 Apr;58(4):209-17. Review.PMID: 18324913 [PubMed - indexed for MEDLINE]Related articles

    16.

    Benign, atypical and malignant lymphoproliferative disorders in rheumatoid arthritis patients.

    Kojima M, Motoori T, Nakamura S.

    Biomed Pharmacother. 2006 Dec;60(10):663-72. Epub 2006 Oct 19. Review.PMID: 17064872 [PubMed - indexed for MEDLINE]Related articles

    17.

    NK-cell repertoire is feasible for diagnosing Epstein-Barr virus-infected NK-cell lymphoproliferative disease and evaluating the treatment effect.

    Sawada A, Sato E, Koyama M, Higuchi B, Kusuki S, Kim JY, Takeshita Y, Sakata A, Sakata N, Okamura T, Yasui M, Inoue M, Kawa K.

    Am J Hematol. 2006 Aug;81(8):576-81.PMID: 16823820 [PubMed - indexed for MEDLINE]Related articles

    18.

    Search for correlation of CD8 T cell response to Epstein-Barr virus with clinical status in rheumatoid arthritis: a 15 month followup pilot study.

    Berthelot JM, Saulquin X, Coste-Burel M, Peyrat MA, Echasserieau K, Bonneville M, Houssaint E.

    J Rheumatol. 2003 Aug;30(8):1673-9.PMID: 12913921 [PubMed - indexed for MEDLINE]Related articles

    19.

    Fulminant EBV(+) T-cell lymphoproliferative disorder following acute/chronic EBV infection: a distinct clinicopathologic syndrome.

    Quintanilla-Martinez L, Kumar S, Fend F, Reyes E, Teruya-Feldstein J, Kingma DW, Sorbara L, Raffeld M, Straus SE, Jaffe ES.

    Blood. 2000 Jul 15;96(2):443-51.PMID: 10887104 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Semiquantitative Epstein-Barr virus (EBV) polymerase chain reaction for the determination of patients at risk for EBV-induced lymphoproliferative disease after stem cell transplantation.

    Lucas KG, Burton RL, Zimmerman SE, Wang J, Cornetta KG, Robertson KA, Lee CH, Emanuel DJ.

    Blood. 1998 May 15;91(10):3654-61.PMID: 9573001 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination
    Write to the Help Desk